Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EQUIA Forte HT Fil
- Development stage
- Unknown
- Lead developer
- GC Biopharma
- Administration
- Topical
01
Overview
EQUIA Forte HT Fil is a dental restorative material developed by GC, representing an advanced glass hybrid technology. It is designed for bulk-fill applications in posterior teeth, including Class I, II, and V restorations. The system consists of a restorative material (Fil) and a protective resin coating (Coat). The Fil component is composed of fluoro-aluminosilicate glass particles of varying sizes and reactivity, which are mixed with high molecular weight polyacrylic acid. This combination allows for a high-viscosity, self-curing material that chemically bonds to the tooth structure (specifically hydroxyapatite) and releases fluoride ions to aid in remineralization and the prevention of secondary caries. Clinical studies, such as those conducted at Cairo University, have compared its performance against resin-modified glass ionomers (RMGI) for treating cervical carious lesions, focusing on aesthetic and mechanical durability.
- Brand names
- EQUIA Forte HT FilEQUIA Forte HT
- Other names
- Advanced Glass HybridAGH
Beyond the preview
Go deeper on EQUIA Forte HT Fil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EQUIA Forte HT Fil.